SCHEMBL5879482

SCHEMBL5879482

C=CCc1cc(C)cc(CC=C)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.50
ALOX15 P16050 2/20 0.50
ACHE P22303 1/20 0.43
POLB P06746 2/20 0.42
ALDH1A1 P00352 4/20 0.41
PPARG P37231 1/20 0.41
PPARD Q03181 1/20 0.41
PPARA Q07869 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
ALOX12 P18054 1/20 0.41
ALOX5 P09917 3/20 0.39
GABRA1 P14867 2/20 0.39
CNR2 P34972 2/20 0.39
GABRB2 P47870 2/20 0.39
DHFR P00374 1/20 0.38
AR P10275 1/20 0.38
PTGS1 P23219 1/20 0.38
TRPM8 Q7Z2W7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14594233 0.90 CYP3A4 (0.46) CYP3A4ALOX15ACHEPOLBALDH1A1
SCHEMBL8451613 0.84 CYP3A4 (0.51) CYP3A4ALOX15POLBALDH1A1PPARG
SCHEMBL770139 0.83 ALDH1A1 (0.50) CYP3A4ALOX15POLBALDH1A1PPARG
SCHEMBL14372999 0.82 KDM4E (0.44) CYP3A4ALOX15ACHEPOLBALDH1A1
SCHEMBL16200754 0.81 PTPN1 (0.41) CYP3A4ALOX15ACHEPOLBALDH1A1
SCHEMBL14373013 0.81 HSD17B10 (0.41) CYP3A4ALOX15ALDH1A1PPARASMN1; SMN2
SCHEMBL25318875 0.80 ACHE (0.47) CYP3A4ALOX15ACHEPOLBALDH1A1
SCHEMBL14372984 0.80 KDM4E (0.39) CYP3A4ALOX15POLBALDH1A1SMN1; SMN2
SCHEMBL16200753 0.79 ALDH1A1 (0.41) CYP3A4ALOX15POLBALDH1A1PPARG
SCHEMBL44672 0.78 GABRA1 (0.48) CYP3A4ALOX15POLBALDH1A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7141684-B2 Diepoxide derivatives of diallyl phenolics PEWS R GARTH 2006-11-28 US disclosed
US-20050090673-A1 Novel diepoxide derivatives of diallyl phenolics PEWS R G (US) 2005-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090673-A1 Novel diepoxide derivatives of diallyl phenolics EBP, EED, ESR2 CYP3A4 251/4885ALOX15 171/4885ACHE 4534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.